Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
Matthew J. Armstrong(Queen Elizabeth University Hospital), Philip N. Newsome(King's College London), Richard Lilford(University of Birmingham), Louise Bentham(University of Birmingham), Paramjit Gill(Coventry (United Kingdom)), Diarmaid D. Houlihan(Queen Elizabeth University Hospital), Jean C. Shaw(NIHR Birmingham Liver Biomedical Research Unit), James Neuberger(Queen Elizabeth Hospital Birmingham), Simon Olliff(Queen Elizabeth University Hospital), Robert Cramb(Queen Elizabeth Hospital Birmingham)
Cited by 304
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Pathogenesis of non-alcoholic fatty liver disease
|QJM|2009|732
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
|Liver Transplantation|2012|544
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
|Journal of Hepatology|2020|525
Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit
|American Journal of Transplantation|2010|505